NovoCure Ltd
NVCR · XNASCIK 1645113fmd_123AB0KYNFZPMKNRD92MJQDGDHManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2013 to Sep 30, 2026, 50 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 83 | 177 | 248 | 351 | 494 | 535 | 538 | 509 | 605 | 655 |
| Cost of revenue | 40 | 56 | 80 | 89 | 107 | 115 | 115 | 128 | 137 | 167 |
| Net interest income | – | – | – | – | – | – | 8 | – | – | – |
| Gross profit | 37 | 121 | 168 | 263 | 388 | 420 | 423 | 381 | 468 | 488 |
| Research and development | 41 | 38 | 51 | 79 | 132 | 201 | 206 | 223 | 210 | 225 |
| Selling, general and administrative | 110 | 123 | 151 | 185 | 225 | 263 | 306 | 391 | 429 | 418 |
| Total operating expenses | 152 | 161 | 202 | 264 | 357 | 464 | 512 | 614 | 639 | 642 |
| Operating income | (115) | (39) | (34) | (1) | 30 | (44) | (90) | (233) | (170) | (154) |
| Interest expense | 7 | 12 | 17 | 15 | 18 | 9 | 8 | 5 | 12 | 22 |
| Interest and investment income | 1 | 1 | 3 | 4 | 2 | 1 | 11 | 20 | 23 | 13 |
| Income before taxes | (121) | (48) | (46) | (9) | 18 | (52) | (82) | (192) | (131) | (136) |
| Income tax expense | 10 | 13 | 18 | (2) | (2) | 6 | 11 | 15 | 37 | (0) |
| Net income from continuing operations | (132) | (62) | (64) | (7) | 20 | (58) | (93) | (207) | (169) | (136) |
| Net income | (132) | (62) | (64) | (7) | 20 | (58) | (93) | (207) | (169) | (136) |
| Net income to common shareholders | – | – | (64) | (7) | 20 | (58) | (93) | (207) | (169) | (136) |